GentiBio
Alaina is an Associate Scientist, at Vector Core. Prior to Genti, Alaina worked as a Viral Vector Manufacturing Associate at MassBiologics where she executed GMP processes to produce and purify AAV for clinical-grade gene therapy products. Alaina received her BS in Chemical Engineering from Manhattan College and played on Manhattan’s NCAA DI women’s lacrosse team (Go Jaspers!).
This person is not in any offices
GentiBio
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.